PGE synthesis (prostaglandin E synthase, PGES), which converts cyclooxygenase (COX)-derived prostaglandin (PG) H2 to PGE2, occurs in multiple forms with distinct enzymatic properties, modes of expression, cellular and subcellular localizations and intracellular functions. Cytosolic PGES (cPGES) is a cytosolic protein that is constitutively expressed in a wide variety of cells and tissues and is associated with heat shock protein 90 (Hsp90). Membrane-associated PGES (mPGES), the expression of which is stimulus-inducible and is downregulated by anti-inflammatory glucocorticoids, is a perinuclear protein belonging to the microsomal glutathione S-transferase (GST) family.
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
CSN12019 | Suprofen | 40828-46-4 | Suprofen is a COX12 inhibitor and a non-steroidal anti-inflammatory drug (NSAID). |
CSN16384 | Pranoprofen | 52549-17-4 | Pranoprofen is a non-steroidal COX inhibitor with anti-inflammatory effects, used in treatment of ophthalmology. |
CSN32919 | Pizuglanstat | 1244967-98-3 | Pizuglanstat is a hematopoietic prostaglandin synthase inhibitor. |
CSN18534 | MF63 | 892549-43-8 | MF63 is a selective mPGES-1 inhibitor with an IC50 of 0.9 nM and 1.3 nM for pig mPGES-1 and human mPGES-1 enzyme, respectively. |
CSN17603 | hPGDS-IN-1 | 1234708-04-3 | hPGDS-IN-1 is a hPGDS inhibitor ,with IC50 of 12 nM in the Fluorescence Polarization Assay or the EIA assay. |
CSN12831 | HPGDS inhibitor 1 | 1033836-12-2 | HPGDS inhibitor 1 is a selective Hematopoietic Prostaglandin D Synthase (HPGDS) inhibitor with an IC50 Value of 0.7 nM. |
CSN24192 | HPGDS inhibitor 2 | 2101626-26-8 | GSK-2894631A is a highly potent and selective HPGDS inhibitor with IC50 value of 9.9nM. |
CSN11044 | Flurbiprofen | 5104-49-4 | Flurbiprofen is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. |
CSN10466 | Bismuth Subsalicylate | 14882-18-9 | Bismuth subsalicylate is the active ingredient in Pepto-Bismol and inhibits prostaglandin GH Synthase 12 |
CSN27768 | AT-56 | 162640-98-4 | AT 56 is an orally active L-PGDS inhibitor with IC50 value of 95μM. It inhibits the production of PGD2 from PGH2 in vitro, with no effect on PGE2 or PGF2α production. |
CSN38729 | PGS-IN-1 | 102271-49-8 | |
CSN75978 | YS121 | 916482-17-2 |